Drug crimes are extremely common in Texas, and people can face criminal charges for possessing either illegal drugs or even certain legal drugs when they are not properly authorized to do so. When you have questions about your drug crime charges, you will want to be sure you speak to a drug crime attorney.
Many people have multiple questions about their arrests and criminal charges, and this FAQ page will hopefully answer some of the most commonly asked questions. All alleged offenders need to remember that an arrest is not itself a conviction, and there can be defenses that may allow for people to get their criminal charges reduced or dismissed.
Drug Crime Defense Lawyer in Denton, Frisco, Lewisville, Flower Mound, TX
If you were arrested for an alleged drug crime, you will benefit from having our firm handle your case because we have handled scores of drug cases all over Texas.
Contact the Law Offices of Richard C. McConathy today at (940) 222-8004 for a consultation about your alleged offense in Denton, Frisco, Lewisville, Flower Mound, and surrounding areas of Denton County, Texas.
What is drug possession in Texas?
Texas Penal Code § 1.07(39) defines possession as being “actual care, custody, control, or management.” Possession may be actual or constructive.
How are actual possession and constructive possession different?
Actual possession is when drugs are found on the person of an alleged offender, meaning drugs being in a person’s hands, pockets, or a purse or backpack. Constructive possession relates to drugs being found in a place in which multiple people had access, but one person is charged with a drug crime based on constructive possession when authorities believe an alleged offender was the person who was the owner of the drugs discovered in such a location.
What are the Texas Drug Penalty Groups?
Drug Penalty Groups are found in the Texas Controlled Substances Act under Chapter 481 of the Texas Health and Safety Code. Drug Penalty Groups include Penalty Group 1 under Texas Health and Safety Code § 481.102, which includes Allylprodine, Alfentanil, Benzethidine, Alphacetylmethadol, Clonitazene, Betaprodine, Diethylthiambutene, Diampromide, Dimenoxadol, Difenoxin not listed in Penalty Group 3 or 4, Dioxaphetyl butyrate, Dimethylthiambutene, Ethylmethylthiambutene, Dipipanone, Etoxeridine, Etonitazene, Hydroxypethidine, Furethidine, Levophenacylmorphan, Ketobemidone, Methadol, Meprodine, Morpheridine, Moramide, Norlevorphanol, Noracymethadol, Norpipanone, Normethadone, Phenampromide, Phenadoxone, Phenoperidine, Phenomorphan, Proheptazine, Piritramide, Propiram, Properidine, Tilidine, Sufentanil, Acetorphine, Trimeperidine, Benzylmorphine, Acetyldihydrocodeine, Codeine-N-Oxide, Codeine methylbromide, Desomorphine, Cyprenorphine, Drotebanol, Dihydromorphine, Heroin, Etorphine except hydrochloride salt, Methyldesorphine, Hydromorphinol, Monoacetylmorphine, Methyldihydromorphine, Morphine methylsulfonate, Morphine methylbromide, Myrophine, Morphine-N-Oxide, Nicomorphine, Nicocodeine, Pholcodine, Normorphine, Opium and opiates not listed in Penalty Group 3 or 4, and a salt, compound, derivative, or preparation of opium or opiate, other than thebaine derived butorphanol, nalmefene and its salts, naloxone and its salts, and naltrexone and its salts, but including Codeine not listed in Penalty Group 3 or 4, Thebacon, Ethylmorphine not listed in Penalty Group 3 or 4, Dihydroetorphine, Hydrocodone not listed in Penalty Group 3, Granulated opium, Metopon, Hydromorphone, Opium extracts, Morphine not listed in Penalty Group 3, Oripavine, Opium fluid extracts, Oxymorphone, Oxycodone, Raw opium, Powdered opium, Tincture of opium, Thebaine, a salt, compound, isomer, derivative, or preparation of a substance that is chemically equivalent or identical to a substance described by Texas Health and Safety Code § 481.102(A), other than the isoquinoline alkaloids of opium, Cocaine, Opium poppy and poppy straw, concentrate of poppy straw, meaning crude extract of poppy straw in liquid, solid, or powder form containing the phenanthrine alkaloids of the opium poppy, Alpha-methylthiofentanyl (N-[1-methyl-2-(2- thienyl)ethyl-4-piperidinyl]-N-phenylpropanamide), Acetyl-alpha-methylfentanyl (N-[1-(1-methyl-2- phenethyl)-4-piperidinyl]-N-phenylacetamide), Anileridine, Beta-hydroxyfentanyl (N-[1-(2-hydroxy-2- phenethyl)-4-piperidinyl] -N-phenylpropanamide), Alphaprodine, Bezitramide, Beta-hydroxy-3-methylfentanyl, Dihydrocodeine not listed in Penalty Group 3 or 4, Carfentanil, Isomethadone, Diphenoxylate not listed in Penalty Group 3 or 4, Levorphanol, Levomethorphan, Methadone, Metazocine, 4-cyano-2-dimethylamino- 4, Methadone-Intermediate, 3-methylthiofentanyl(N-[3-methyl-1-(2-thienyl) ethyl-4-piperidinyl]-N-phenylpropanamide), 4-diphenyl butane, 3-methylfentanyl(N-[3-methyl-1-(2-phenylethyl)- 4-piperidyl]-N-phenylpropanamide), 2-methyl-3-morpholino-1, Moramide-Intermediate, Para-fluorofentanyl(N-(4-fluorophenyl)-N-1-(2- phenylethyl)-4-piperidinylpropanamide), 1-diphenyl-propane-carboxylic acid, Pethidine (Meperidine), PEPAP (1-(2-phenethyl)-4-phenyl-4- acetoxypiperidine), Pethidine-Intermediate-A, 4-cyano-1-methyl-4- phenylpiperidine, Pethidine-Intermediate-B, ethyl-4- phenylpiperidine-4 carboxylate, Pethidine-Intermediate-C, 1-methyl-4- phenylpiperidine-4-carboxylic acid, Phenazocine, Piminodine, Racemethorphan, Racemorphan, Remifentanil, Thiofentanyl(N-phenyl-N-[1-(2-thienyl)ethyl-4- piperidinyl]-propanamide), Flunitrazepam (trade or other name: Rohypnol), Methamphetamine, including its salts, optical isomers, and salts of optical isomers, Phenylacetone and methylamine, if possessed together with intent to manufacture methamphetamine, Phencyclidine, including its salts, Gamma hydroxybutyric acid (some trade or other names such as: gamma hydroxybutyrate (GHB), including its salts, Ketamine, Phenazepam, U-47700, AH-7921, ADB-FUBINACA, AMB-FUBINACA, and MDMB-CHMICA. Penalty Group 1-A under Texas Health and Safety Code § 481.1021 includes lysergic acid diethylamide (LSD), including its salts, isomers, and salts of isomers, compounds structurally derived from 2,5-dimethoxyphenethylamine by substitution at the 1-amino nitrogen atom with a benzyl substituent, including compounds further modified by substitution in the phenethylamine ring at the 4-position to any extent (including alkyl, alkoxy, alkylenedioxy, haloalkyl, or halide substituents), or substitution in the benzyl ring to any extent (including alkyl, alkoxy, alkylenedioxy, haloalkyl, or halide substituents) and by example, compounds such as 4-Chloro-2,5-dimethoxy-N-(2-methoxybenzyl)phenethylamine (trade or other names: 25C-NBOMe, 4-Bromo-2,5-dimethoxy-N-(2-methoxybenzyl)phenethylamine (trade or other names: 25B-NBOMe, 2C-B-NBOMe), 2,5-Dimethoxy-4-methyl-N-(2-methoxybenzyl)phenethylamine (trade or other names: 25D-NBOMe, 2C-D-NBOMe), 2C-C-NBOMe), 2,5-Dimethoxy-N-(2- methoxybenzyl)phenethylamine (some trade and other names: 25H-NBOMe, 2C-H-NBOMe), 4-Ethyl-2,5-dimethoxy-N-(2-methoxybenzyl)phenethylamine (trade or other names: 25E-NBOMe, 2C-E-NBOMe), 4-Iodo-2,5-dimethoxy-N- benzylphenethylamine (trade or other name: 25I-NB), 4-Iodo-2,5-dimethoxy-N-(2-methoxybenzyl)phenethylamine (some trade and other names: 25I-NBOMe, 2C-I-NBOMe), 4-Iodo-2,5-dimethoxy-N-(2- fluorobenzyl)phenethylamine (trade or other name: 25I-NBF), 4-Iodo-2,5-dimethoxy-N-(2,3- methylenedioxybenzyl)phenethylamine (trade or other name: 25I-NBMD), 2,5-Dimethoxy-4-nitro-N-(2-methoxybenzyl)phenethylamine (trade or other names: 25N-NBOMe, 2C-N-NBOMe), 4-Iodo-2,5-dimethoxy-N-(2-hydroxybenzyl)phenethylamine (trade or other name: 25I-NBOH), and 2,5-Dimethoxy-4-(n)-propyl-N-(2- methoxybenzyl)phenethylamine (some trade and other names: 25P-NBOMe, 2C-P-NBOMe). Penalty Group 2 under Texas Health and Safety Code § 481.103 includes any quantity of the following hallucinogenic substances, their salts, isomers, and salts of isomers, unless specifically excepted, if the existence of the salts, isomers, and salts of isomers is possible within the specific chemical designation 6-(2-aminopropyl)benzofuran (6-APB), 5-(2-aminopropyl)benzofuran (5-APB), 5-(2-aminopropyl)-2,3-dihydrobenzofuran (5-APDB), 5-(2-aminopropyl)indole (5-IT,5-API), 6-(2-aminopropyl)-2,3-dihydrobenzofuran (6-APDB), 1-(benzofuran-5-yl)-N-methylpropan-2-amine (5-MAPB), 6-(2-aminopropyl)indole (6-IT,6-API), Benzothiophenylcyclohexylpiperidine (BTCP), 1-(benzofuran-6-yl)-N-methylpropan-2-amine (6-MAPB), Desoxypipradrol (2-benzhydrylpiperidine), 8-bromo-alpha-methyl-benzo[1,2-b:4,5-b’]difuran- 4-ethanamine (trade or other name: Bromo-DragonFLY), Diphenylprolinol (diphenyl(pyrrolidin-2-yl) methanol, D2PM), 2, 5-dimethoxyamphetamine (some trade or other names: 2, 5-dimethoxy-alpha-methylphenethylamine; 2, 5-DMA), Dronabinol (synthetic) in sesame oil and encapsulated in a soft gelatin capsule in a United States Food and Drug Administration approved drug product (some trade or other names for Dronabinol: Ethylamine Analog of Phencyclidine (some trade or other names: N-ethyl-1-phenylcyclohexylamine, (1- phenylcyclohexyl) ethylamine, (a6aR-trans)-6a,7,8,10a-tetrahydro- 6,6, 9- trimethyl-3-pentyl-6H- dibenzo [b,d]pyran-1-ol or (-)-delta-9- (trans)- tetrahydrocannabinol), cyclohexamine, (PCE), N-(1-phenylcyclohexyl) ethylamine, Ibogaine (some trade or other names: 7-Ethyl-6, 6, beta 7, 8, 9, 10, 12, 13-octahydro-2-methoxy-6, 9-methano-5H- pyrido [1′, 2′:1, 2] azepino [5, 4-b] indole; tabernanthe iboga.), 2-ethylamino-2-(3-methoxyphenyl)cyclohexanone (trade or other name: methoxetamine), Mescaline, 5-iodo-2-aminoindane (5-IAI), 4-methoxymethamphetamine (PMMA), 4-methoxyamphetamine (some trade or other names: 4-methoxy-alpha-methylphenethylamine; paramethoxyamphetamine; PMA), 1-methyl- 4-phenyl-4-propionoxypiperidine (MPPP, PPMP), 2-(2-methoxyphenyl)-2-(methylamino)cyclohexanone (some trade and other names: 2-MeO-ketamine; methoxyketamine), 4-methyl-2, 5-dimethoxyamphetamine (some trade and other names: 4-methyl-2, 5-dimethoxy-alpha- methylphenethylamine; “DOM”; “STP”), 5-methoxy-3, 4-methylenedioxy amphetamine, 3,4-methylenedioxy amphetamine, 3,4-methylenedioxy methamphetamine (MDMA, MDM), 5,6-methylenedioxy-2-aminoindane (MDAI), 3,4-methylenedioxy N-ethylamphetamine (Also known as N-ethyl MDA), N-ethyl-3-piperidyl benzilate, N-hydroxy-3,4-methylenedioxyamphetamine (Also known as N-hydroxy MDA), Nabilone (Another name for nabilone: (+)-trans- 3-(1,1-dimethylheptyl)- 6,6a, 7,8,10,10a-hexahydro-1-hydroxy- 6, 6-dimethyl-9H-dibenzo[b,d] pyran-9-one, N-benzylpiperazine (some trade or other names: BZP; 1-benzylpiperazine), Parahexyl (some trade or other names: 3-Hexyl-1- hydroxy-7, 8, 9, 10-tetrahydro-6, 6, 9-trimethyl-6H-dibenzo [b, d] pyran; Synhexyl), 1-Phenylcyclohexylamine, 1-Piperidinocyclohexanecarbonitrile (PCC), 4-methylaminorex, N-methyl-3-piperidyl benzilate, Tetrahydrocannabinols, other than marijuana, and synthetic equivalents of the substances contained in the plant, or in the resinous extractives of Cannabis, or synthetic substances, derivatives, and their isomers with similar chemical structure and pharmacological activity such as delta-1 cis or trans tetrahydrocannabinol, and their optical isomers, delta-6 cis or trans tetrahydrocannabinol, and their optical isomers, delta-3, 4 cis or trans tetrahydrocannabinol, and its optical isomers, compounds of these structures, regardless of numerical designation of atomic positions, since nomenclature of these substances is not internationally standardized, Pyrrolidine Analog of Phencyclidine (some trade or other names: 1-(1-phenylcyclohexyl)-pyrrolidine, PCPy, PHP), Thiophene Analog of Phencyclidine (some trade or other names: 1-[1-(2-thienyl) cyclohexyl] piperidine; 2-Thienyl Analog of Phencyclidine; TPCP, TCP), 1-pyrrolidine (some trade or other name: TCPy), 1-(3-trifluoromethylphenyl)piperazine (trade or other name: TFMPP), 3,4,5-trimethoxy amphetamine, Phenylacetone (some trade or other names: Phenyl-2-propanone; P2P, Benzymethyl ketone, methyl benzyl ketone), unless specifically excepted or unless listed in another Penalty Group, a material, compound, mixture, or preparation that contains any quantity of the following substances having a potential for abuse associated with a depressant or stimulant effect on the central nervous system: Amphetamine, its salts, optical isomers, and salts of optical isomers, Aminorex (some trade or other names: aminoxaphen; 2-amino-5-phenyl-2-oxazoline; 4,5-dihydro-5- phenyl-2-oxazolamine), Etaqualone and its salts, Cathinone (some trade or other names: 2-amino-1- phenyl-1-propanone, alpha-aminopropiophenone, 2- aminopropiophenone), Fenethylline and its salts, Etorphine Hydrochloride, Mecloqualone and its salts, Lisdexamfetamine, including its salts, isomers, and salts of isomers, Methcathinone (some trade or other names: 2- methylamino-propiophenone; alpha-(methylamino)propriophenone; 2-(methylamino)-1-phenylpropan-1-one; alpha-N- methylaminopropriophenone; monomethylpropion; ephedrone, N- methylcathinone; methylcathinone; AL-464; AL-422; AL-463; and UR 1431), Methaqualone and its salts, N,N-dimethylamphetamine (some trade or other names: N,N,alpha-trimethylbenzeneethanamine; N,N,alpha-trimethylphenethylamine), its salts, optical isomers, and salts of optical isomers, any compound structurally derived from 2-aminopropanal by substitution at the 1-position with any monocyclic or fused-polycyclic ring system, including: compounds further modified by: substitution in the ring system to any extent (including alkyl, alkoxy, alkylenedioxy, haloalkyl, or halide substituents), whether or not further substituted in the ring system by other substituents, substitution at the 3-position with an alkyl substituent, substitution at the 2-amino nitrogen atom with alkyl, benzyl, dialkyl, or methoxybenzyl groups, or inclusion of the 2-amino nitrogen atom in a cyclic structure, compounds such as 4-Methylmethcathinone (Also known as Mephedrone), N-Ethylamphetamine, its salts, optical isomers, and salts of optical isomers, 3-Fluoromethcathinone (Also known as 3-FMC), 3,4-Dimethylmethcathinone (Also known as 3,4-DMMC), 3,4-Methylenedioxy-N-methylcathinone (Also known as Methylone), 4-Fluoromethcathinone (Also known as Flephedrone), alpha-Pyrrolidinopentiophenone (Also known as alpha-PVP), 3,4-Methylenedioxypyrovalerone (Also known as MDPV), alpha-Methylamino-valerophenone (Also known as Pentedrone), Naphthylpyrovalerone (Also known as Naphyrone), beta-Keto-N-methylbenzodioxolylpentanamine (Also known as Pentylone), beta-Keto-N-methylbenzodioxolylpropylamine (Also known as Butylone), 3,4-methylenedioxy-N-ethylcathinone (Also known as Ethylone), beta-Keto-Ethylbenzodioxolylbutanamine (Also known as Eutylone), any compound structurally derived from tryptamine (3-(2-aminoethyl)indole) or a ring-hydroxy tryptamine by modification in any of the following ways: by substitution at the amine nitrogen atom of the sidechain to any extent with alkyl or alkenyl groups or by inclusion of the amine nitrogen atom of the side chain (and no other atoms of the side chain) in a cyclic structure, by substitution at the carbon atom adjacent to the nitrogen atom of the side chain (alpha-position) with an alkyl or alkenyl group, by substitution in the 6-membered ring to any extent with alkyl, alkoxy, haloalkyl, thioaklyl, alkylenedioxy, or halide substituents, or by substitution at the 2-position of the tryptamine ring system with an alkyl substituent, and including: ethers and esters of the controlled substances listed in this subdivision, and by example, compounds such as alpha-methyltryptamine, alpha-ethyltryptamine, Diethyltryptamine (some trade and other names: N, N-Diethyltryptamine, DET), Dimethyltryptamine (trade or other name: DMT), Bufotenine (some trade and other names: 3-(beta-Dimethylaminoethyl)-5-hydroxyindole; 3-(2-dimethylaminoethyl)- 5- indolol; N, N-dimethylserotonin; 5-hydroxy-N, N- dimethyltryptamine; mappine), N-diisopropyltryptamine (5-MeO-DiPT), 5-methoxy-N, Psilocin, O-Acetylpsilocin (Trade or other name: 4-Aco-DMT), Psilocybin, 2,5-Dimethoxyphenethylamine and any compound structurally derived from 2,5-Dimethoxyphenethylamine by substitution at the 4-position of the phenyl ring to any extent (including alkoxy, alkyl, haloalkyl, alkylenedioxy, or halide substituents), including, by example, compounds such as: 4-Chloro-2,5-dimethoxyphenethylamine (trade or other name: 2C-C), 4-Bromo-2,5-dimethoxyphenethylamine (trade or other name: 2C-B), 4-Ethyl-2,5-dimethoxyphenethylamine (trade or other name: 2C-E), 2,5-Dimethoxy-4-methylphenethylamine (trade or other name: 2C-D), 2,5-Dimethoxy-4-nitrophenethylamine (trade or other name: 2C-N), 4-Iodo-2,5-dimethoxyphenethylamine (trade or other name: 2C-I), 4-Ethylthio-2,5-dimethoxyphenethylamine (trade or other name: 2C-T-2), 2,5-Dimethoxy-4-(n)-propylphenethylamine (trade or other name: 2C-P), 2,5-Dimethoxy-4-(n)-propylthiophenethylamine (trade or other name: 2C-T-7), 4-Isopropylthio-2,5-dimethoxyphenethylamine (trade or other name: 2C-T-4), 2,5-Dimethoxyamphetamine and any compound structurally derived from 2,5-Dimethoxyamphetamine by substitution at the 4-position of the phenyl ring to any extent (including alkyl, alkoxy, alkylenedioxy, haloalkyl, or halide substituents), including, by example, compounds such as: 4-Isopropylthio-2,5-dimethoxyamphetamine (trade or other name: Aleph-4), 4-Ethylthio-2,5-dimethoxyamphetamine (trade or other name: Aleph-2), 4-Chloro-2,5-dimethoxyamphetamine (trade or other name: DOC), 4-Bromo-2,5-dimethoxyamphetamine (trade or other name: DOB), 4-Iodo-2,5-dimethoxyamphetamine (trade or other name: DOI), 2,5-Dimethoxy-4-ethylamphetamine (trade or other name: DOET), 2,5-Dimethoxy-4-nitroamphetamine (trade or other name: DON), 2,5-Dimethoxy-4-methylamphetamine (trade or other name: DOM), 2,5-Dimethoxy-4-(n)-propylamphetamine (trade or other name: DOPR), and 4-Isopropyl-2,5-dimethoxyamphetamine (trade or other name: DOIP), and 4-Isopropyl-2,5-dimethoxyamphetamine (trade or other name: DOIP). Penalty Group 2-A under Texas Health and Safety Code § 481.1031 includes WIN-55,212-2, Cyclohexylphenol: any compound structurally derived from 2-(3-hydroxycyclohexyl)phenol by substitution at the 5-position of the phenolic ring, (N-methylpiperidin-2-yl)alkyl, (4-tetrahydropyran)alkyl, or 2-(4-morpholinyl)alkyl, whether or not substituted in the cyclohexyl ring to any extent, including: JWH-344, JWH-337, CP-47,497, CP-55,940, and analogues of CP-47,497, Cannabinol derivatives, except where contained in marijuana, including tetrahydro derivatives of cannabinol and 3-alkyl homologues of cannabinol or of its tetrahydro derivatives, such as: HU-210, Nabilone, and HU-211, Tetramethylcyclopropyl thiazole: any compound structurally derived from 2,2,3,3-tetramethyl-N-(thiazol- 2-ylidene)cyclopropanecarboxamide by substitution at the nitrogen atom of the thiazole ring, whether or not further substituted in the thiazole ring to any extent, whether or not substituted in the tetramethylcyclopropyl ring to any extent, including: A-836,339, any compound containing a core component substituted at the 1-position to any extent, and substituted at the 3-position with a link component attached to a group A component, whether or not the core component or group A component are further substituted to any extent, including: Naphthoylindazole (THJ-018), Naphthoylindane, Naphthoylindole (JWH-018), Naphthyl methyl indene (JWH-171), Naphthoyl pyrazolopyridine, Quinolinoyl pyrazole carboxylate (Quinolinyl fluoropentyl fluorophenyl pyrazole carboxylate), and Naphthoylpyrrole (JWH-030), any compound containing a core component substituted at the 1-position to any extent, and substituted at the 2-position with a link component attached to a group A component, whether or not the core component or group A component are further substituted to any extent, including: Naphthoylimidazole, Naphthoylbenzimidazole (JWH-018 Benzimidazole), and any compound containing a core component substituted at the 3-position to any extent, and substituted at the 2-position with a link component attached to a group A component, whether or not the core component or group A component are further substituted to any extent, including: Naphthoyl benzothiazole and any compound containing a core component substituted at the 9-position to any extent, and substituted at the 3-position with a link component attached to a group A component, whether or not the core component or group A component are further substituted to any extent, including: Naphthoylcarbazole (EG-018). Penalty Group 3 under Texas Health and Safety Code § 481.104 includes Methylphenidate and its salts and Phenmetrazine and its salts, a material, compound, mixture, or preparation that contains any quantity of the following substances having a potential for abuse associated with a depressant effect on the central nervous system, a substance that contains any quantity of a derivative of barbituric acid, or any salt of a derivative of barbituric acid not otherwise described by this subsection, a compound, mixture, or preparation containing secobarbital, amobarbital, pentobarbital, or any salt of any of these, and one or more active medicinal ingredients that are not listed in any penalty group, a suppository dosage form containing secobarbital, amobarbital, pentobarbital, or any salt of any of these drugs, and approved by the United States Food and Drug Administration for marketing only as a suppository, Amobarbital, Alprazolam, Camazepam, Bromazepam, Chlordiazepoxide, Carisoprodol, Clobazam, Chlorhexadol, Clorazepate, Clonazepam, Cloxazolam, Clotiazepam, Diazepam, Delorazepam, Ethyl loflazepate, Estazolam, Fludiazepam, Etizolam, Glutethimide, Flurazepam, Haloxzolam, Halazepam, Loprazolam, Ketazolam, Lormetazepam, Lorazepam, Lysergic acid amide, including its salts, isomers, and salts of isomers, Lysergic acid, including its salts, isomers, and salts of isomers, Medazepam, Mebutamate, Midazolam, Methyprylon, Nitrazepam, Nimetazepam, Oxazepam, Nordiazepam, Pentazocine, its salts, derivatives, or compounds or mixtures thereof, Oxazolam, Pinazepam, Pentobarbital, Quazepam, Prazepam, Sulfondiethylmethane, Secobarbital, Sulfonmethane, Sulfonethylmethane, Tetrazepam, Temazepam, Tiletamine and zolazepam in combination, and its salts. (some trade or other names for a tiletamine-zolazepam combination product: Telazol, for tiletamine: 2-(ethylamino)- 2-(2-thienyl)-cyclohexanone, and for zolazepam: 4-(2- fluorophenyl)-6, 8-dihydro-1,3,8,-trimethylpyrazolo-[3,4- e](1,4)-d diazepin-7(1H)-one, flupyrazapon), Triazolam, Tramadol, Zolpidem, Zaleplon, Zopiclone, Nalorphine, a material, compound, mixture, or preparation containing limited quantities of the following narcotic drugs, or any of their salts: not more than 1.8 grams of codeine, or any of its salts, per 100 milliliters or not more than 90 milligrams per dosage unit, with one or more active, nonnarcotic ingredients in recognized therapeutic amounts, not more than 1.8 grams of codeine, or any of its salts, per 100 milliliters or not more than 90 milligrams per dosage unit, with an equal or greater quantity of an isoquinoline alkaloid of opium, not more than 300 milligrams of dihydrocodeinone (hydrocodone), or any of its salts, per 100 milliliters or not more than 15 milligrams per dosage unit, with a fourfold or greater quantity of an isoquinoline alkaloid of opium, not more than 300 milligrams of dihydrocodeinone (hydrocodone), or any of its salts, per 100 milliliters or not more than 15 milligrams per dosage unit, with one or more active, nonnarcotic ingredients in recognized therapeutic amounts, not more than 1.8 grams of dihydrocodeine, or any of its salts, per 100 milliliters or not more than 90 milligrams per dosage unit, with one or more active, nonnarcotic ingredients in recognized therapeutic amounts, not more than 300 milligrams of ethylmorphine, or any of its salts, per 100 milliliters or not more than 15 milligrams per dosage unit, with one or more active, nonnarcotic ingredients in recognized therapeutic amounts, not more than 500 milligrams of opium per 100 milliliters or per 100 grams, or not more than 25 milligrams per dosage unit, with one or more active, nonnarcotic ingredients in recognized therapeutic amounts, not more than 50 milligrams of morphine, or any of its salts, per 100 milliliters or per 100 grams with one or more active, nonnarcotic ingredients in recognized therapeutic amounts; not more than 1 milligram of difenoxin and not less than 25 micrograms of atropine sulfate per dosage unit, a material, compound, mixture, or preparation that contains any quantity of the following substances: Chloral betaine, Barbital, Ethchlorvynol, Chloral hydrate, Meprobamate, Ethinamate, Methylphenobarbital (Mephobarbital), Methohexital, Petrichloral, Paraldehyde, Phenobarbital, Peyote, unless unharvested and growing in its natural state, meaning all parts of the plant classified botanically as Lophophora, whether growing or not, the seeds of the plant, an extract from a part of the plant, and every compound, manufacture, salt, derivative, mixture, or preparation of the plant, its seeds, or extracts, unless listed in another penalty group, a material, compound, mixture, or preparation that contains any quantity of the following substances having a stimulant effect on the central nervous system, including the substance’s salts, optical, position, or geometric isomers, and salts of the substance’s isomers, if the existence of the salts, isomers, and salts of isomers is possible within the specific chemical designation: Cathine [(+)-norpseudoephedrine], Benzphetamine, Clortermine, Chlorphentermine, Fencamfamin, Diethylpropion, Fenproporex, Fenfluramine, Mefenorex, Mazindol, Pemoline (including organometallic complexes and their chelates), Modafinil, Phentermine, Phendimetrazine, Sibutramine, Pipradrol, SPA [(-)-1-dimethylamino-1,2-diphenylethane], unless specifically excepted or unless listed in another penalty group, a material, compound, mixture, or preparation that contains any quantity of the following substance, including its salts: Dextropropoxyphene (Alpha-(+)-4-dimethylamino- 1,2-diphenyl-3-methyl-2-propionoxybutane), an anabolic steroid, including any drug or hormonal substance, or any substance that is chemically or pharmacologically related to testosterone, other than an estrogen, progestin, dehydroepiandrosterone, or corticosteroid, and promotes muscle growth, including the following drugs and substances and any salt, ester, or ether of the following drugs and substances, Androstanedione, Androstanediol, Androstenedione, Androstenediol, Boldenone, Bolasterone, Clostebol, Calusterone, Delta-1-dihydrotestosterone, Dehydrochlormethyltestosterone, Drostanolone, Dihydrotestosterone (4-dihydrotestosterone), Fluoxymesterone, Ethylestrenol, Furazabol, Formebulone, 4-hydroxytestosterone, 13beta-ethyl-17beta-hydroxygon-4-en-3-one, Mestanolone, 4-hydroxy-19-nortestosterone, Methandienone, Mesterolone, Methenolone, Methandriol, 17 beta-dihydroxy-5alpha- androstane, 17alpha-methyl-3beta, 17 beta-dihydroxy-5alpha- androstane, 17alpha-methyl-3alpha, 17beta-dihydroxyandrost-4- ene, 17alpha-methyl-3beta, Methyldienolone, 17alpha-methyl-4-hydroxynandrolone, Methyltrienolone, Methyltestosterone, Mibolerone, 17alpha-methyl-delta-1-dihydrotestosterone, Norandrostenediol, Nandrolone, Norbolethone, Norandrostenedione, Norethandrolone, Norclostebol, Oxandrolone, Normethandrolone, Oxymetholone, Oxymesterone, Stenbolone, Stanozolol, Testosterone, Testolactone, Trenbolone, Tetrahydrogestrinone, and Salvia divinorum, unless unharvested and growing in its natural state, meaning all parts of that plant, whether growing or not, the seeds of that plant, an extract from a part of that plant, and every compound, manufacture, salt, derivative, mixture, or preparation of that plant, its seeds, or extracts, including Salvinorin A. Penalty Group 4 under Texas Health and Safety Code § 481.105 includes a compound, mixture, or preparation containing limited quantities of any of the following narcotic drugs that includes one or more nonnarcotic active medicinal ingredients in sufficient proportion to confer on the compound, mixture, or preparation valuable medicinal qualities other than those possessed by the narcotic drug alone: not more than 100 milligrams of dihydrocodeine per 100 milliliters or per 100 grams, not more than 200 milligrams of codeine per 100 milliliters or per 100 grams, not more than 2.5 milligrams of diphenoxylate and not less than 25 micrograms of atropine sulfate per dosage unit, not more than 100 milligrams of ethylmorphine per 100 milliliters or per 100 grams, not more than 0.5 milligram of difenoxin and not less than 25 micrograms of atropine sulfate per dosage unit, and not more than 15 milligrams of opium per 29.5729 milliliters or per 28.35 grams.
Does marijuana remain illegal in Texas?
The Texas Tribune noted in July 2022 that marijuana remains illegal to use or possess in Texas, and this has been the case since 1931. The one major change in 2019 was hemp becoming considered to be different from marijuana because it was made federally legal by the 2018 Farm Bill and through House Bill 1325 in Texas, which Governor Greg Abbott signed in 2019, leading to CBD products being sold throughout the state. Manufacturing can be another issue. Although hemp may be legal to buy, sell, and possess, the Texas Department of State Health Services still bans the processing and manufacturing of smokable hemp within the state. Medical cannabis is also legal in Texas in very limited circumstances through the Texas Compassionate Use Program, which allows Texans with certain medical conditions—such as epilepsy, autism, cancer, and post-traumatic stress disorder (PTSD)—to access cannabis oil with less than 1 percent THC by weight.
How does a drug crime conviction affect my job prospects?
Employers have the ability to review the criminal records of applicants, and people could face possible job loss when an employer decides that a drug conviction is a fireable offense. Not all employers learn about drug charges, so people can give themselves the best protection for their employment by fighting criminal charges to achieve resolutions other than convictions that do not cause as many issues.
Are there other consequences to drug crime convictions?
Because every drug crime conviction can appear on a criminal record, it can impact far more than just a person’s job status. Some people who are applying for apartments or other housing may have landlords using drug convictions against them and make them the basis for a denial. People applying for professional licensing might also face struggles in approval because of drug convictions. Students at colleges can face possible discipline from their institutions for certain drug crimes. Other people can be denied public benefits for drug convictions.
Will a drug crime affect my driver’s license status?
Yes, it may. The Texas Department of Public Safety (DPS) states that people convicted of drug crimes can have their driver’s licenses suspended for 180 days, may be required to complete a 15-hour Drug Education Program class, pay a $100 reinstatement fee as well as any other outstanding fees that are owed, and obtain a Financial Responsibility Insurance Certificate (more commonly known as an SR-22) from an authorized insurance company that people must maintain for two years from the dates of their convictions. If a person does not have a driver’s license at the time of a drug crime, they could be denied the issuance of a driver’s license for 180 days.
When can the police search my motor vehicle?
Police officers typically need to have search warrants to search you or your property. When it comes to traffic stops, police officers will only need probable cause to search a motor vehicle. The alleged odor of marijuana is frequently cited as the basis for most motor vehicle searches. You can always state that you do not consent to a search, and refusing to consent to a search in which police find drugs in your vehicle may allow an attorney to possibly claim that a search violated your Fourth Amendment rights.
Can a person be charged with driving while intoxicated (DWI) for allegedly being under the influence of drugs?
Absolutely. While DWI is more commonly associated with alcohol, a person can also be arrested for being intoxicated by drugs. Remember that while the definition of intoxicated under Texas Penal Code § 49.01(2) is having an alcohol concentration of 0.08 or more, it also means “not having the normal use of mental or physical faculties by reason of the introduction of alcohol, a controlled substance, a drug, a dangerous drug, a combination of two or more of those substances, or any other substance into the body.” When a police officer believes an alleged offender is under the influence of drugs, a drug recognition expert is usually summoned to complete a series of tests to determine if an alleged offender is impaired by drugs. Drug recognition experts often follow the same 12-step process, which is a breath alcohol test, an interview of the arresting officer, a preliminary examination and first pulse, an eye examination, divided attention psychophysical tests, vital signs and second pulse, dark room examinations, an examination for muscle tone, a check for injection sites and third pulse, the subject’s statements and other observations, an analysis and opinions of the evaluator, and a toxicological examination. The entire drug recognition expert process is inherently flawed because the interview of an arresting officer is the second step in the process and all subsequent tests thus serve as more of a confirmation bias.
May drug crime convictions be sealed or expunged in Texas?
Possibly, but not necessarily in all cases. Expungement (or expunction) is only available to people acquitted of the crimes for which they were charged, people who were convicted but subsequently found to be innocent, people convicted but subsequently pardoned, people charged but cases later dismissed and the statute of limitations expired, or people arrested but not formally charged. Drug crimes are not usually included in possible offenses that prohibit orders of nondisclosure to seal records, so a person may be able to seal a criminal record with a drug conviction.
Denton County Drug Crime Resources
Drug Report – Texas Department of Public Safety (DPS) — This DPS document states that the total number of arrests for drug abuse in Texas for 2020 was 88,651, which was the lowest total of the past 10 years. It was actually synthetic narcotics that accounted for the most drug sales and manufacturing offenses, even more than opium or cocaine and marijuana. Marijuana remains responsible for more possession arrests than synthetic narcotics or opium or cocaine, although other drugs actually accounted for the most.
Substance Abuse and Crime in Texas: A Summary of Prison and Probation Surveys Conducted by the Texas Commission on Alcohol and Drug Abuse and Evaluations of the Texas Criminal Justice Treatment Initiative — This United States Department of Justice document presents findings from prison and probation surveys conducted by the Texas Commission on Alcohol and Drug Abuse and evaluations of the Texas Criminal Justice Treatment Initiative conducted from 1988 through 1998. There are sections on the use of both licit and illicit substance use, including lifetime and use in the past month while on the street, the need for treatment, and criminal history. The findings showed that in terms of substance use and treatment needs, 63 percent of prison inmates and 59 percent of probationers are either substance abusers or substance dependent, and a vast majority were unable to afford treatment.
Find A Denton County Defense Attorney for Drug Crimes | The Law Offices of Richard C. McConathy
Were you arrested for a drug crime anywhere in Denton County? It will be critical for you to seek the help of a criminal defense lawyer before you make any court appearance.
Contact the Law Offices of Richard C. McConathy today at (940) 222-8004 for a consultation about your alleged offense in Denton, Frisco, Lewisville, Flower Mound, and surrounding areas of Denton County, Texas. Our firm can take the time to thoroughly review your case and talk to you about what you might be able to do.